Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Axim Biotechnologies
(OP:
AXIM
)
0.5799
USD
-0.0501 (-7.95%)
Official Closing Price
Updated: 3:59 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
175,800
Open
0.6240
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.6300
Today's Range
0.5100 - 0.6760
52wk Range
0.1000 - 1.440
Shares Outstanding
56,736,450
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients
February 03, 2021
From
GlobeNewswire News Releases
AXIM® Biotechnologies Releases Preprint Manuscript Describing the Development of Company’s Rapid Point-of-Care Test That Measures COVID-19 Neutralizing Antibodies
January 11, 2021
From
GlobeNewswire News Releases
Performance
YTD
+39.73%
+39.73%
1 Month
-0.70%
-0.70%
3 Month
+38.07%
+38.07%
6 Month
-6.47%
-6.47%
1 Year
+146.87%
+146.87%
More News
Read More
AXIM® Biotechnologies Completes Successful Covid-19 Live Virus Test and Files Amended EUA for Portable 10 Minute Rapid Diagnostic Test for Neutralizing Antibodies
December 15, 2020
From
GlobeNewswire News Releases
AXIM® Biotechnologies to Present at the 13th Annual LD Micro Main Event Investor Conference on Monday, December 14
December 14, 2020
From
GlobeNewswire News Releases
AXIM® Biotechnologies Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for Patent; Company’s Fourth COVID-19 Test-Focused Patent Application
December 03, 2020
From
GlobeNewswire News Releases
AXIM® Biotechnologies Applauds Vaccine Producers, Highlights Need for Rapid Antibody Testing to Ensure Immunity
November 10, 2020
From
GlobeNewswire News Releases
AXIM® Biotechnologies Issues Update Letter to Shareholders
October 28, 2020
From
GlobeNewswire News Releases
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for World’s First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)
October 06, 2020
From
GlobeNewswire News Releases
Medical Marijuana, Inc. Investment Company AXIM Biotechnologies Files Patent for Worlds First Face Mask Designed to Capture SARS-CoV-2 (COVID-19)
October 06, 2020
From
NewMediaWire
AXIM® Biotechnologies Files Patent for Virus Binding Recombinant Protein for SARS-CoV-2 (COVID-19) and Begins Manufacturing
September 30, 2020
From
GlobeNewswire News Releases
AXIM® Biotechnologies Files Patent for World’s First Face Mask Designed to Capture SARS-CoV-2 COVID-19
September 29, 2020
From
GlobeNewswire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.